• Jhonny Peralta To Rejoin Tigers, But No Decision To Activate Yet

    Comments:  | Leave A Comment

    Jhonny Peralta will rejoin the Detroit Tigers on Wednesday, Team President Dave Dombrowski told reporters before  Tuesday.

    Dombrowski said no decision has been made with regards to activating Peralta. His suspension ends September 26.

    The team released the following statement:

    “In accordance with the protocols outlined by Major League Baseball’s collective bargaining agreement, Jhonny Peralta will join the club for workouts in Chicago beginning on Wednesday. There has been no decision made regarding Peralta’s return to the active roster. It is an organizational decision to allow Jhonny to workout with the club in order to see if it will be in the best interest of the team to have him return at the end of his suspension.”

    On August 5, the shortstop was suspended for 50 games by Major League Baseball Commissioner Bud Selig. Peralta is one of 14 Major League Baseball players with ties to the Biogenesis clinic who were disciplined for violating the league’s Joint Drug Agreement.

    The Tigers acquired Jose Iglesias from the Boston Red Sox, who has played shortstop in Peralta’s absence.

    In a statement released to the media soon after the suspension, Peralta said, “In spring of 2012, I made a terrible mistake that I deeply regret. I apologize to everyone that I have hurt as a result of my mistake, including my teammates, the Tigers’ organization, the great fans in Detroit, Major League Baseball, and my family. I take full responsibility for my actions, have no excuses for my lapse in judgment and I accept my suspension.

    “I love the fans, my teammates and this organization and my greatest punishment is knowing that I have let so many good people down. I promise to do everything possible to try and earn back the respect that I have lost.”

    If Peralta returns, he will have only three regular season games to play before the playoffs.

    PERALTA

    Join the Conversation! Share and Discuss!

    Tags:

    • More Related Content

    Comments

    blog comments powered by Disqus
    Follow

    Get every new post delivered to your Inbox.

    Join 343 other followers